These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 3939614

  • 21. Fatal liver failure in children on valproate.
    Scheffner D.
    Lancet; 1986 Aug 30; 2(8505):511. PubMed ID: 2875255
    [No Abstract] [Full Text] [Related]

  • 22. Incidental microvesicular steatosis due to valproic acid anticonvulsant therapy.
    Scott DA, Gholson CF, Netchvolodoff CV, Ray M, Gonzalez E, Bacon BR.
    Am J Gastroenterol; 1991 Apr 30; 86(4):500-2. PubMed ID: 1901443
    [Abstract] [Full Text] [Related]

  • 23. Sodium valproate (Epilim) in epilepsy: a trial.
    Briant RH, Foote SE, Wallis WE.
    N Z Med J; 1978 Dec 27; 88(626):479-82. PubMed ID: 105332
    [Abstract] [Full Text] [Related]

  • 24. Hepatotoxicity of sodium valproate.
    Berkovic SF, Bladin PF, Jones DB, Smallwood RA, Vajda FJ.
    Clin Exp Neurol; 1983 Dec 27; 19():192-7. PubMed ID: 6150774
    [Abstract] [Full Text] [Related]

  • 25. Plasma levels of sodium valproate in childhood epilepsy.
    McQueen JK, Blackwood DH, Minns RA, Brown JK.
    Scott Med J; 1982 Oct 27; 27(4):312-7. PubMed ID: 6815799
    [Abstract] [Full Text] [Related]

  • 26. Sodium valproate and the liver.
    Lancet; 1980 Nov 22; 2(8204):1119-20. PubMed ID: 6107730
    [No Abstract] [Full Text] [Related]

  • 27. Sodium valproate and hepatotoxicity in epileptics.
    Beran RG, Rischbieth RH.
    Med J Aust; 1979 Dec 01; 2(11):603-4. PubMed ID: 119151
    [No Abstract] [Full Text] [Related]

  • 28. [Fatal hepatic failure in a normally developed 5-year-old boy caused by VPA monotherapy].
    König S, Scheffner D, Rauterberg-Ruland I, Kochen W, Hofmann WJ, Wokittel E, Schick U.
    Monatsschr Kinderheilkd; 1987 Jun 01; 135(6):310-3. PubMed ID: 3112563
    [Abstract] [Full Text] [Related]

  • 29. [Comparative study of valproic acid and sodium valproate (author's transl)].
    Sorel L, Rucquoy-Ponsar M, Willems C, Diepart E, Harmant J.
    Acta Neurol Belg; 1981 Jun 01; 81(5):283-90. PubMed ID: 6797226
    [Abstract] [Full Text] [Related]

  • 30. Reversible hepatotoxicity, pancreatitis, coagulation disorder and simultaneous bone marrow suppression with valproate in a 2-year-old girl.
    Gerstner T, Bauer MO, Longin E, Bell N, Koenig SA.
    Seizure; 2007 Sep 01; 16(6):554-6. PubMed ID: 17493839
    [Abstract] [Full Text] [Related]

  • 31. Fatal hepatotoxicity in child on phenobarbitone and sodium valproate.
    Jacobi G, Thorbeck R, Ritz A, Janssen W, Schmidts HL.
    Lancet; 1980 Mar 29; 1(8170):712-3. PubMed ID: 6103126
    [No Abstract] [Full Text] [Related]

  • 32. Valproate sodium in epilepsy. A clinical trial including monitoring of drug levels.
    Mehrotra TN, Aneja GK, Arora V, Goel S, Singh VS.
    J Assoc Physicians India; 1990 Apr 29; 38(4):277-9. PubMed ID: 2118134
    [Abstract] [Full Text] [Related]

  • 33. Acute hyperammonemic coma with chronic valproic acid therapy.
    Cuturic M, Abramson RK.
    Ann Pharmacother; 2005 Dec 29; 39(12):2119-23. PubMed ID: 16288075
    [Abstract] [Full Text] [Related]

  • 34. Sodium valproate (Epilim) in the treatment of refractory epilepsy.
    Lines DR.
    N Z Med J; 1978 Jan 11; 87(603):9-12. PubMed ID: 347342
    [Abstract] [Full Text] [Related]

  • 35. Sodium valproate "encephalopathy": report of three cases with generalised epilepsy.
    Tartara A, Manni R.
    Ital J Neurol Sci; 1985 Mar 11; 6(1):93-5. PubMed ID: 3922913
    [Abstract] [Full Text] [Related]

  • 36. Reversible valproate-induced choreiform movements.
    Gunal DI, Guleryuz M, Bingol CA.
    Seizure; 2002 Apr 11; 11(3):205-6. PubMed ID: 12018966
    [Abstract] [Full Text] [Related]

  • 37. Effect of L-carnitine treatment for valproate-induced hepatotoxicity.
    DeVivo DC.
    Neurology; 2002 Feb 12; 58(3):507-8. PubMed ID: 11839873
    [No Abstract] [Full Text] [Related]

  • 38. Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity.
    Bicknese AR, May W, Hickey WF, Dodson WE.
    Ann Neurol; 1992 Dec 12; 32(6):767-75. PubMed ID: 1471867
    [Abstract] [Full Text] [Related]

  • 39. Acute liver disease associated with sodium valproate.
    Ware S, Millward-Sadler GH.
    Lancet; 1980 Nov 22; 2(8204):1110-3. PubMed ID: 6107726
    [Abstract] [Full Text] [Related]

  • 40. Plasma concentrations of sodium valproate: their clinical value.
    Turnbull DM, Rawlins MD, Weightman D, Chadwick DW.
    Ann Neurol; 1983 Jul 22; 14(1):38-42. PubMed ID: 6412620
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.